BackErytech Pharma Overview

Erytech Pharma Total Current Liabilities

Latest total current liabilities for ERYP: $0.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$0.00

Peer average

Loading

Erytech Pharma Total Current Liabilities History

Loading

Erytech Pharma vs. peers: Total Current Liabilities Comparison

Loading

Erytech Pharma Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Erytech Pharma (ERYP) FAQ

Erytech Pharma (ERYP) currently reports a total current liabilities of $0 as of March 2023. Use the charts on this page to explore Erytech Pharma's total current liabilities history and peer comparisons.

Erytech Pharma reported $0 in total current liabilities as of March 2023. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Erytech Pharma, and consider following ERYP for alerts when major investors trade the stock.

Erytech Pharma is classified in the Healthcare sector. On total current liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ERYP with unrelated industries.